1fvn

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1fvn" size="450" color="white" frame="true" align="right" spinBox="true" caption="1fvn" /> '''[ALA31, AIB32]-NEUROPEPTIDE Y'''<br /> ==Ov...)
Line 1: Line 1:
-
[[Image:1fvn.gif|left|200px]]<br /><applet load="1fvn" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1fvn.gif|left|200px]]<br /><applet load="1fvn" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1fvn" />
caption="1fvn" />
'''[ALA31, AIB32]-NEUROPEPTIDE Y'''<br />
'''[ALA31, AIB32]-NEUROPEPTIDE Y'''<br />
==Overview==
==Overview==
-
The first Y(5) receptor-selective analog of neuropeptide Y (NPY), [Ala(31),Aib(32)]NPY, has been developed and biologically characterized., Using competition binding assays on cell lines that express different Y, receptors, we determined the affinity of this analog to be 6 nm at the, human Y(5) receptor, &gt;500 nm at the Y(1) and Y(2) receptors, and &gt;1000 nm, at the Y(4) receptor. Activity studies performed in vitro using a cAMP, enzyme immunoassay, and in vivo using food intake studies in rats, showed, that the peptide acted as an agonist. Further peptides obtained by the, combination of the Ala(31)-Aib(32) motif with chimeric peptides containing, segments of NPY and pancreatic polypeptide displayed the same selectivity, and even higher affinity (up to 0.2 nm) for the Y(5) receptor. In vivo, administration of the new Y(5) receptor-selective agonists significantly, stimulated feeding in rats. The NMR solution structures of NPY and, [Ala(31),Aib(32)]NPY showed a different conformation in the C-terminal, region, where the alpha-helix of NPY was substituted by a more flexible, 3(10)-helical turn structure.
+
The first Y(5) receptor-selective analog of neuropeptide Y (NPY), [Ala(31),Aib(32)]NPY, has been developed and biologically characterized. Using competition binding assays on cell lines that express different Y receptors, we determined the affinity of this analog to be 6 nm at the human Y(5) receptor, &gt;500 nm at the Y(1) and Y(2) receptors, and &gt;1000 nm at the Y(4) receptor. Activity studies performed in vitro using a cAMP enzyme immunoassay, and in vivo using food intake studies in rats, showed that the peptide acted as an agonist. Further peptides obtained by the combination of the Ala(31)-Aib(32) motif with chimeric peptides containing segments of NPY and pancreatic polypeptide displayed the same selectivity and even higher affinity (up to 0.2 nm) for the Y(5) receptor. In vivo administration of the new Y(5) receptor-selective agonists significantly stimulated feeding in rats. The NMR solution structures of NPY and [Ala(31),Aib(32)]NPY showed a different conformation in the C-terminal region, where the alpha-helix of NPY was substituted by a more flexible, 3(10)-helical turn structure.
==About this Structure==
==About this Structure==
-
1FVN is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/ ] with NH2 as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1FVN OCA].
+
1FVN is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/ ] with <scene name='pdbligand=NH2:'>NH2</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1FVN OCA].
==Reference==
==Reference==
Line 13: Line 13:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Bader, R.]]
[[Category: Bader, R.]]
-
[[Category: Beck-Sickinger, A.G.]]
+
[[Category: Beck-Sickinger, A G.]]
[[Category: Zerbe, O.]]
[[Category: Zerbe, O.]]
[[Category: NH2]]
[[Category: NH2]]
Line 19: Line 19:
[[Category: alpha]]
[[Category: alpha]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 15:20:22 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:43:05 2008''

Revision as of 10:43, 21 February 2008

Image:1fvn.gif

1fvn

Drag the structure with the mouse to rotate

[ALA31, AIB32]-NEUROPEPTIDE Y

Overview

The first Y(5) receptor-selective analog of neuropeptide Y (NPY), [Ala(31),Aib(32)]NPY, has been developed and biologically characterized. Using competition binding assays on cell lines that express different Y receptors, we determined the affinity of this analog to be 6 nm at the human Y(5) receptor, >500 nm at the Y(1) and Y(2) receptors, and >1000 nm at the Y(4) receptor. Activity studies performed in vitro using a cAMP enzyme immunoassay, and in vivo using food intake studies in rats, showed that the peptide acted as an agonist. Further peptides obtained by the combination of the Ala(31)-Aib(32) motif with chimeric peptides containing segments of NPY and pancreatic polypeptide displayed the same selectivity and even higher affinity (up to 0.2 nm) for the Y(5) receptor. In vivo administration of the new Y(5) receptor-selective agonists significantly stimulated feeding in rats. The NMR solution structures of NPY and [Ala(31),Aib(32)]NPY showed a different conformation in the C-terminal region, where the alpha-helix of NPY was substituted by a more flexible, 3(10)-helical turn structure.

About this Structure

1FVN is a Single protein structure of sequence from [1] with as ligand. Full crystallographic information is available from OCA.

Reference

The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats., Cabrele C, Langer M, Bader R, Wieland HA, Doods HN, Zerbe O, Beck-Sickinger AG, J Biol Chem. 2000 Nov 17;275(46):36043-8. PMID:10944518

Page seeded by OCA on Thu Feb 21 12:43:05 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1fvn"
Personal tools